Lumos Diagnostics Holdings Ltd. ( (AU:LDX) ) has provided an announcement.
Lumos Diagnostics Holdings Ltd, a leader in rapid diagnostic technologies, will announce its 1H FY25 financial results on 27 February 2025, followed by an investor briefing on 3 March 2025. The briefing will feature presentations by the CEO and CFO, providing insights into the company’s recent progress and financial performance, with a Q&A session to engage stakeholders.
More about Lumos Diagnostics Holdings Ltd.
Lumos Diagnostics specializes in rapid point-of-care diagnostic test technology, offering customized assay development and manufacturing services for POC tests and proprietary digital reader platforms. The company focuses on developing, manufacturing, and commercializing novel POC tests targeting infectious and inflammatory diseases.
YTD Price Performance: -17.14%
Average Trading Volume: 1,924,546
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$21.71M
Find detailed analytics on LDX stock on TipRanks’ Stock Analysis page.